Primary conjunctival follicular lymphoma treated with the anti-CD20 antibody rituximab and low-dose involved-field radiotherapy

被引：7
|
作者：
Takahira, Masayuki
Okumura, Hirokazu
Minato, Hiroshi
Urushisaki, Norimasa
Sakurai, Mayumi
Sugiyama, Kazuhisa
机构：
[1] Kanazawa Univ, Sch Med, Dept Ophthalmol, Kanazawa, Ishikawa 9208640, Japan
[2] Kanazawa Univ, Sch Med, Dept Hematol, Kanazawa, Ishikawa 920, Japan
[3] Kanazawa Univ Hosp, Pathol Sect, Kanazawa, Ishikawa, Japan
来源：
JAPANESE JOURNAL OF OPHTHALMOLOGY | 2007年 / 51卷 / 02期
关键词：
conjunctiva; follicular lymphoma; gene translocation; low-dose involved field radiotherapy; rituximab;
D O I：
10.1007/s10384-006-0407-0
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：149 / 151
页数：4
相关论文
共 50 条
  • [1] Primary Conjunctival Follicular Lymphoma Treated with the Anti-CD20 Antibody Rituximab and Low-Dose Involved-Field Radiotherapy
    Masayuki Takahira
    Hirokazu Okumura
    Hiroshi Minato
    Norimasa Urushisaki
    Mayumi Sakurai
    Kazuhisa Sugiyama
    [J]. Japanese Journal of Ophthalmology, 2007, 51 : 149 - 151
  • [2] Anti-CD20 (rituximab) in follicular lymphoma
    McLaughlin, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S51 - S51
  • [3] Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma
    Kazutaka Takagi
    Akira Yoshida
    Hiromichi Iwasaki
    Hitoshi Inoue
    Takanori Ueda
    [J]. Annals of Hematology, 2005, 84 : 548 - 550
  • [4] Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma
    Takagi, K
    Yoshida, A
    Iwasaki, H
    Inoue, H
    Ueda, T
    [J]. ANNALS OF HEMATOLOGY, 2005, 84 (08) : 548 - 550
  • [5] Which Anti-CD20 Antibody Is Better in Follicular Lymphoma?
    Armitage, James O.
    Longo, Dan L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14): : 1389 - 1390
  • [6] Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma
    Luthy, S. K.
    Ng, A. K.
    Silver, B.
    Degnan, K. O.
    Fisher, D. C.
    Freedman, A. S.
    Mauch, P. M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (12) : 2043 - 2047
  • [7] LOW-DOSE INVOLVED-FIELD RADIOTHERAPY AS ALTERNATIVE TREATMENT OF NODULAR LYMPHOCYTE PREDOMINANCE HODGKIN'S LYMPHOMA
    Haas, Rick L. M.
    Girinsky, Theo
    Aleman, Berthe M. P.
    Henry-Amar, Michel
    de Boer, Jan-Paul
    de Jong, Daphne
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (04): : 1199 - 1202
  • [8] Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-cd20 monoclonal antibody
    Ahmed, S
    Singh, A
    Krauss, J
    Wentz, T
    Gunaratnam, NT
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 408 - 410
  • [9] Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma
    Vassilakopoulos, TP
    Angelopoulou, MK
    Siakantaris, MP
    Kontopidou, FN
    Dimopoulou, MN
    Kokoris, SI
    Kyrtsonis, MC
    Tsaftaridis, P
    Karkantaris, C
    Anargyrou, K
    Boutsis, DE
    Variamis, E
    Michalopoulos, T
    Boussiotis, VA
    Panayiotidis, P
    Papavassiliou, C
    Pangalis, GA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (03): : 765 - 781
  • [10] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    [J]. ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
12345